Egyptian healthtech company developing and manufacturing affordable, temperature-resilient molecular diagnostic tests for diseases such as TB, HIV, hepatitis and HPV.
| Date | Round | Amount |
|---|---|---|
| Jul 2026 | Seed Reme-D closed a 1.45 million dollar pre-Series A round led by Anara Impact Capital to expand manufacturing capacity, regional reach and its diagnostic product portfolio. The Global Innovation Fund and Africa Health Ventures also participated. | $1.4M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.